Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

被引:615
|
作者
Boers, Maarten [1 ]
Kirwan, John R. [2 ]
Wells, George [3 ]
Beaton, Dorcas [4 ]
Gossec, Laure [5 ,6 ]
d'Agostino, Maria-Antonietta [7 ]
Conaghan, Philip G. [8 ]
Bingham, Clifton O., III [9 ]
Brooks, Peter [10 ]
Landewe, Robert [11 ]
March, Lyn [12 ,13 ]
Simon, Lee S. [14 ]
Singh, Jasvinder A. [15 ,16 ]
Strand, Vibeke [17 ]
Tugwell, Peter [18 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
[2] Univ Bristol, Acad Rheumatol Unit, Bristol Royal Infirm, Bristol, Avon, England
[3] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada
[4] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada
[5] Univ Paris 06, Dept Rheumatol, GRC UMPC EEMOIS 08, Paris, France
[6] Hop La Pitie Salpetriere, AP HP, Paris, France
[7] Univ Versailles St Quentin Yvelines, Dept Rheumatol, Ambroise Pare Hosp, Boulogne, France
[8] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[9] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD 21224 USA
[10] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[11] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[12] Univ Sydney, Kolling Inst Med Res, Inst Bone & Joint Res, Sydney, NSW 2006, Australia
[13] Royal N Shore Hosp, Dept Rheumatol, St Leonards, NSW 2065, Australia
[14] SDG LLC, Cambridge, MA 02138 USA
[15] Univ Alabama Birmingham, Div Rheumatol, Birmingham, AL 35294 USA
[16] Vet Affairs Med Ctr, Birmingham, AL 35294 USA
[17] Stanford Univ, School Med, Div Immunol Rheumatol, Palo Alto, CA 94028 USA
[18] Univ Ottawa, Dept Med, Ottawa, ON, Canada
关键词
Outcome assessment (health care); Clinical trial; Rheumatology; Research design; Biological markers; Reference Standards; RHEUMATOID-ARTHRITIS; PATIENT PERSPECTIVE; QUALITY; CONSENSUS; INSTRUMENTS; FRAMEWORK; COSMIN; AREAS; LIFE;
D O I
10.1016/j.jclinepi.2013.11.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be addressed by agreeing on a minimum core set of outcome measures per health condition, containing measures relevant to patients and decision makers. Since 1992, the Outcome Measures in Rheumatology (OMERACT) consensus initiative has successfully developed core sets for many rheumatologic conditions, actively involving patients since 2002. Its expanding scope required an explicit formulation of its underlying conceptual framework and process. Methods: Literature searches and iterative consensus process (surveys and group meetings) of stakeholders including patients, health professionals, and methodologists within and outside rheumatology. Results: To comprehensively sample patient-centered and intervention-specific outcomes, a framework emerged that comprises three core "Areas," namely Death, Life Impact, and Pathophysiological Manifestations; and one strongly recommended Resource Use. Through literature review and consensus process, core set development for any specific health condition starts by identifying at least one core "Domain" within each of the Areas to formulate the "Core Domain Set." Next, at least one applicable measurement instrument for each core Domain is identified to formulate a "Core Outcome Measurement Set." Each instrument must prove to be truthful (valid), discriminative, and feasible. In 2012, 96% of the voting participants (n = 125) at the OMERACT 11 consensus conference endorsed this model and process. Conclusion: The OMERACT Filter 2.0 explicitly describes a comprehensive conceptual framework and a recommended process to develop core outcome measurement sets for rheumatology likely to be useful as a template in other areas of health care. (C) 2014 The Authors. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:745 / 753
页数:9
相关论文
共 50 条
  • [41] The Omeract Core Domain Set for Clinical Trials in Behcet's Syndrome
    Hatemi, Gulen
    Meara, Alexa
    Ozguler, Yesim
    Direskeneli, Haner
    Mahrs, Alfred
    Shea, Beverly
    Cam, Esen
    Gul, Ahmet
    Yazici, Yusuf
    Tugwell, Peter
    Yazici, Hasan
    Merkel, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [42] How Well Are The Assessment Of Spondyloarthritis International Society (ASAS)/Outcome Measures In Rheumatology (OMERACT) Core Outcome Sets For Ankylosing Spondylitis Implemented In Randomized Clinical Trials? A Systematic Literature Review
    Bautista-Molano, Wilson
    Navarro-Compan, Victoria
    Landewe, Robert
    van der Heijde, Desiree
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S638 - S639
  • [43] Core Outcome Sets in clinical Studies
    Kottner, Jan
    Lechner, Anna
    PFLEGE, 2020, 33 (03): : 177 - 178
  • [44] Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
    Philpott, C.
    Kumaresan, K.
    Fjaeldstad, A. W.
    Macchi, A.
    Monti, G.
    Frasnelli, J.
    Konstantinidis, I.
    Pinto, J.
    Mullol, J.
    Boardman, J.
    Vodicka, J.
    Holbrook, E.
    Ramakrishnan, V. R.
    Lechner, M.
    Hummel, T.
    RHINOLOGY, 2023, 61 (04) : 312 - 319
  • [45] Developing a core outcome set for periodontal trials
    Lamont, Thomas J.
    Clarkson, Jan E.
    Ricketts, David N. J.
    Heasman, Peter A.
    Ramsay, Craig R.
    Gillies, Katie
    PLOS ONE, 2021, 16 (07):
  • [46] Core domain and outcome measurement sets for shoulder pain trials are needed: systematic review of physical therapy trials
    Page, Matthew J.
    McKenzie, Joanne E.
    Green, Sally E.
    Beaton, Dorcas E.
    Jain, Nitin B.
    Lenza, Mario
    Verhagen, Arianne P.
    Surace, Stephen
    Deitch, Jessica
    Buchbinder, Rachelle
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (11) : 1270 - 1281
  • [47] Adoption of core outcome sets in osteoarthritis clinical trials: Still a long way to go
    Smith, Toby O.
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 (06) : 631 - 633
  • [48] The need for standardised outcomes in cancer clinical trials: a report of cancer core outcome sets
    Gargon, Elizabeth
    Altman, Doug
    Blazeby, Jane
    Clarke, Mike
    Williamson, Paula
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 10 - 10
  • [49] Developing a Core Set of Outcome Measures for Behcet Disease: Report from OMERACT 2016
    Hatemi, Gulen
    Meara, Alexa
    Ozguler, Yesim
    Direskeneli, Haner
    Mahr, Alfred
    Easley, Ebony
    Gurcan, Mert
    Davis, Trocon
    Gul, Ahmet
    Yazici, Yusuf
    Zottenberg, Katelyn
    Esatoglu, Sinem Nihal
    Erer, Burak
    Kamali, Sevil
    Yazici, Hasan
    Cronholm, Peter F.
    Merkel, Peter A.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (11) : 1750 - 1753
  • [50] Recommendations for a core outcome measurement set for clinical trials in whiplash associated disorders
    Sterling, Michele
    Andersen, Tonny
    Carroll, Linda
    Connelly, Luke
    Cote, Pierre
    Curatolo, Michele
    Grant, Genevieve
    Jull, Gwendolen
    Kasch, Helge
    Ravn, Sophie Lykkegaard
    Macdermid, Joy
    Malmstrom, Eva-Maj
    Rebbeck, Trudy
    Soderlund, Anne
    Treleaven, Julia
    Walton, David M.
    Westergren, Hans
    PAIN, 2023, 164 (10) : 2265 - 2272